Form 4: NeuroPace Director Acquires Shares in Compensation

NeuroPace Director Frank M. Fischer acquired 1,431 shares of common stock at $16.59 per share as part of his non-employee director compensation policy.

Summary

• Frank M. Fischer, a Director of NeuroPace Inc. (NPCE), acquired 1,431 shares of common stock.
• The transaction occurred on December 19, 2025, with shares priced at $16.59 each.
• These shares were issued in lieu of quarterly retainer fees, consistent with the company's non-employee director compensation policy.
• Following this acquisition, Mr. Fischer beneficially owns a total of 593,351 shares of NeuroPace common stock.

Sentiment

Score: 6

Explanation: The filing indicates a routine, expected transaction where a director receives shares as compensation, which is generally viewed as a neutral to slightly positive sign of alignment with shareholder interests. No significant positive or negative news is conveyed.

Positives

• Director Frank M. Fischer increased his direct ownership in NeuroPace Inc. by acquiring 1,431 shares.
• The acquisition demonstrates alignment of director interests with shareholder interests, as shares were received as compensation.

Negatives

• No negative aspects are indicated in this Form 4 filing.

Risks

• This Form 4 filing does not contain information regarding company-specific risks.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This routine insider transaction, a director receiving shares as compensation, is a common practice across various industries and does not inherently reflect broader industry trends or competitive dynamics. It primarily indicates standard corporate governance practices for director remuneration within NeuroPace Inc.

Comparison to Industry Standards

• The practice of compensating non-employee directors with equity, such as common stock, is a widely accepted corporate governance standard across U.S. publicly traded companies, including those in the medical technology and biotechnology sectors like NeuroPace.
• This aligns with common industry practices aimed at aligning the interests of directors with those of shareholders.

Corporate Governance

Related Party Transactions

• The acquisition of 1,431 shares by Director Frank M. Fischer is a related party transaction, as it involves a company director receiving compensation in the form of equity from the issuer.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director, even as compensation, can be seen as a minor positive signal of management's alignment with shareholder interests.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

• This Form 4 filing does not mention any specific future actions, events, or milestones.

Key Dates

Keywords

NeuroPace, NPCE, Form 4, Insider Trading, Director Compensation, Stock Acquisition, Frank Fischer, Beneficial Ownership